Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition
- 30 April 2004
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 317 (2), 463-471
- https://doi.org/10.1016/j.bbrc.2004.03.066
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- COX-2: A Target for Colon Cancer PreventionAnnual Review of Pharmacology and Toxicology, 2002
- Cyclooxygenase-2: A Therapeutic TargetAnnual Review of Medicine, 2002
- Many actions of cyclooxygenase‐2 in cellular dynamics and in cancerJournal of Cellular Physiology, 2002
- Dietary Inulin Improves Distal Colitis Induced by Dextran Sodium Sulfate in the RatThe American Journal of Gastroenterology, 2001
- Intracellular unesterified arachidonic acid signals apoptosisProceedings of the National Academy of Sciences of the United States of America, 2000
- Dietary resistant starch and chronic inflammatory bowel diseasesInternational Journal of Colorectal Disease, 1999
- Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer CellsCell, 1998
- Prostaglandins in the Stomach: An UpdateJournal of Clinical Gastroenterology, 1998
- Colorectal Cancer and Nonsteroidal Anti-inflammatory DrugsAdvances in pharmacology, 1997
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995